A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

American Psychiatric Association, 2000, Diagnostic and statistical manual of mental disorders, fourth ed., text rev. Author, Washington, DC Avants, 2000, A randomized controlled trial of auricular acupuncture for cocaine dependence, Arc. Intern. Med., 160, 2305, 10.1001/archinte.160.15.2305 Baker, 2003, Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse, Nat. Neurosci., 6, 743, 10.1038/nn1069 Bickel, 1988, A clinical trial of buprenorphine:Comparison with methadone in the detoxification of heroin addicts, Clin. Pharmacol. Ther., 43, 72, 10.1038/clpt.1988.13 Budney, 2002, Development and consequences of cannabis dependence, J. Clin. Pharmacol., 42, 28, 10.1002/j.1552-4604.2002.tb06000.x Budney, 2006, Clinical trial of abstinence-based vouchers and cognitive-behavioral therapies for cannabis dependence, J. Consult. Clin. Psychol., 74, 307, 10.1037/0022-006X.74.2.307 Cooper, 2015, Psychological and psychosocial interventions for cannabis cessation in adults:A systematic review short report, Health Technol. Assess., 19, 1 Copeland, 2016, Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review, Subst. Abuse Rehabil., 7, 41, 10.2147/SAR.S89857 First, 2004 Gates, 2016, Psychosocial interventions for cannabis use disorder, Cochrane Database Syst. Rev., 5, CD005336 Gray, 2012, A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents, Am. J. Psychiatry, 169, 805, 10.1176/appi.ajp.2012.12010055 Haney, 2013, Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status, Biol. Psychiatry, 73, 242, 10.1016/j.biopsych.2012.07.028 Hasin, 2015, Prevalence of marijuana use disorders in the United States between 2001 and 2002 and 2012–2013, JAMA Psychiatry, 72, 1235, 10.1001/jamapsychiatry.2015.1858 Hasin, 2016, Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the national epidemiological survey on alcohol and related conditions-III, Am. J. Psychiatry, 173, 588, 10.1176/appi.ajp.2015.15070907 Heishman, 2009, Reliability and validity of a short form of the Marijuana Craving Questionnaire, Drug Alcohol Depend., 102, 35, 10.1016/j.drugalcdep.2008.12.010 Herron, 2013, Assessment of riboflavin as a tracer substance:Comparison of a qualitative to a quantitative method of riboflavin measurement, Drug Alcohol Depend., 128, 77, 10.1016/j.drugalcdep.2012.08.007 Johnson, 2007, Topiramate for treating alcohol dependence: a randomized controlled trial, JAMA, 298, 1641, 10.1001/jama.298.14.1641 Liang, 1986, Longitudinal data analysis using generalized linear models, Biometrika, 73, 13, 10.1093/biomet/73.1.13 Malcolm, 2000, A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence, Drug Alcohol Depend., 60, 161, 10.1016/S0376-8716(99)00151-9 Mariani, 2011, Quantification and comparison of marijuana smoking practicesBlunts, joints, and pipes, Drug Alcohol Depend., 113, 249, 10.1016/j.drugalcdep.2010.08.008 Marshall, 2014, Pharmacotherapies for cannabis dependence, Cochrane Database Syst. Rev., 12, CD008940 McClure, 2014, Potential role of N-acetylcysteine in the management of substance use disorders, CNS Drugs, 28, 95, 10.1007/s40263-014-0142-x McClure, 2014, Achieving cannabis cessation −evaluating N-acetylcysteine treatment ACCENT): design and implementation of a multi-site, randomized controlled study in the national institute on drug abuse clinical trials network, Contemp. Clin. Trials, 39, 211, 10.1016/j.cct.2014.08.011 Molton, 2016, Prospective single-arm interventional pilot study to assess a smartphone-based system for measuring and supporting adherence to medication, BMJ, 6, e014194 Montgomery, 2012, Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults, Drug Alcohol Depend., 126, 333, 10.1016/j.drugalcdep.2012.05.033 Montgomery, 2015, Initial abstinence status and contingency management treatment outcomes: does race matter?, J. Consult. Clin. Psychol., 83, 473, 10.1037/a0039021 Peters, 2014, Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence, Drug Alcohol Depend., 134, 228, 10.1016/j.drugalcdep.2013.10.003 Peterson, 2016, Video chat technology to remotely quantify dietary, supplement and medication adherence in clinical trials, Br. J. Nutr., 116, 1646, 10.1017/S0007114516003524 Sheehan, 1998, The mini-international neuropsychiatric interview M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J. Clin. Psychiatry, 59, 22 Sobell, 1988, Reliability of a timeline method:Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations, Br. J. Addict., 83, 393, 10.1111/j.1360-0443.1988.tb00485.x Trivedi, 2017, Randomized controlled trial comparing exercise to health education for stimulant use disorder: results from the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study, J. Clin. Psychiatry, 10.4088/JCP.15m10591 Volkow, 2014, Adverse health effects of marijuana use, N. Engl. J. Med., 370, 2219, 10.1056/NEJMra1402309 Volpicelli, 2001 Winhusen, 2014, Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence, J. Clin. Psychiatry, 75, 757, 10.4088/JCP.13m08862